{"entity":{"type":"insider","cik":"0001915598","url":"/insider/0001915598","json_url":"/insider/0001915598.json","name":"Friedl-Naderer Johanna","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":9,"first":"2023-03-07","last":"2026-08-17","span_basis":"filed_date"},"name_variants":[{"name":"Friedl-Naderer Johanna","source":"filing","n_filings":9,"first_seen":"2023-03-07","last_seen":"2026-08-17"}],"transactions":[{"id":9296727,"accession":"0001915598-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001915598-26-000004","line_url":"/filing/0001915598-26-000004#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001915598","owner_name":"Friedl-Naderer Johanna","owner_display_name":"Friedl-Naderer Johanna","owner_url":"/insider/0001915598","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":226.0,"shares_display":"226","price_per_share":26.28,"price_display":"26.28","price_state":"stated","total_value":5939.28,"total_display":"5,939.28","total_whole":"5,939","shares_owned_after":153982.0,"shares_owned_after_display":"153,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-13","filed_date":"2026-08-17","scope":"insider"},{"id":5902454,"accession":"0001915598-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001915598-26-000002","line_url":"/filing/0001915598-26-000002#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001915598","owner_name":"Friedl-Naderer Johanna","owner_display_name":"Friedl-Naderer Johanna","owner_url":"/insider/0001915598","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":145.0,"shares_display":"145","price_per_share":18.33,"price_display":"18.33","price_state":"stated","total_value":2657.85,"total_display":"2,657.85","total_whole":"2,658","shares_owned_after":154208.0,"shares_owned_after_display":"154,208","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-16","filed_date":"2026-06-17","scope":"insider"},{"id":6002112,"accession":"0001193125-26-223984","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-223984","line_url":"/filing/0001193125-26-223984#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001915598","owner_name":"Friedl-Naderer Johanna","owner_display_name":"Friedl-Naderer Johanna","owner_url":"/insider/0001915598","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":228.0,"shares_display":"228","price_per_share":18.36,"price_display":"18.36","price_state":"stated","total_value":4186.08,"total_display":"4,186.08","total_whole":"4,186","shares_owned_after":154353.0,"shares_owned_after_display":"154,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-13","filed_date":"2026-05-14","scope":"insider"},{"id":5929802,"accession":"0001193125-26-096523","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-096523","line_url":"/filing/0001193125-26-096523#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001915598","owner_name":"Friedl-Naderer Johanna","owner_display_name":"Friedl-Naderer Johanna","owner_url":"/insider/0001915598","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":148.0,"shares_display":"148","price_per_share":14.9,"price_display":"14.90","price_state":"stated","total_value":2205.2,"total_display":"2,205.20","total_whole":"2,205","shares_owned_after":154581.0,"shares_owned_after_display":"154,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-06","scope":"insider"},{"id":4991103,"accession":"0001193125-25-309636","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-309636","line_url":"/filing/0001193125-25-309636#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001915598","owner_name":"Friedl-Naderer Johanna","owner_display_name":"Friedl-Naderer Johanna","owner_url":"/insider/0001915598","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":144.0,"shares_display":"144","price_per_share":20.72,"price_display":"20.72","price_state":"stated","total_value":2983.68,"total_display":"2,983.68","total_whole":"2,984","shares_owned_after":94729.0,"shares_owned_after_display":"94,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-05","scope":"insider"},{"id":4314311,"accession":"0000950170-25-113545","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-113545","line_url":"/filing/0000950170-25-113545#line-2","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001915598","owner_name":"Friedl-Naderer Johanna","owner_display_name":"Friedl-Naderer Johanna","owner_url":"/insider/0001915598","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":144.0,"shares_display":"144","price_per_share":13.41,"price_display":"13.41","price_state":"stated","total_value":1931.04,"total_display":"1,931.04","total_whole":"1,931","shares_owned_after":94873.0,"shares_owned_after_display":"94,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-05","filed_date":"2025-09-08","scope":"insider"},{"id":4314304,"accession":"0000950170-25-113545","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-113545","line_url":"/filing/0000950170-25-113545#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001915598","owner_name":"Friedl-Naderer Johanna","owner_display_name":"Friedl-Naderer Johanna","owner_url":"/insider/0001915598","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":894.0,"shares_display":"894","price_per_share":13.27,"price_display":"13.27","price_state":"stated","total_value":11863.38,"total_display":"11,863.38","total_whole":"11,863","shares_owned_after":95017.0,"shares_owned_after_display":"95,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-04","filed_date":"2025-09-08","scope":"insider"},{"id":5118311,"accession":"0000950170-25-083033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-083033","line_url":"/filing/0000950170-25-083033#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001915598","owner_name":"Friedl-Naderer Johanna","owner_display_name":"Friedl-Naderer Johanna","owner_url":"/insider/0001915598","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":146.0,"shares_display":"146","price_per_share":13.35,"price_display":"13.35","price_state":"stated","total_value":1949.1,"total_display":"1,949.10","total_whole":"1,949","shares_owned_after":95911.0,"shares_owned_after_display":"95,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-05","filed_date":"2025-06-06","scope":"insider"},{"id":5197063,"accession":"0000950170-25-038750","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-038750","line_url":"/filing/0000950170-25-038750#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001915598","owner_name":"Friedl-Naderer Johanna","owner_display_name":"Friedl-Naderer Johanna","owner_url":"/insider/0001915598","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":143.0,"shares_display":"143","price_per_share":12.12,"price_display":"12.12","price_state":"stated","total_value":1733.16,"total_display":"1,733.16","total_whole":"1,733","shares_owned_after":96057.0,"shares_owned_after_display":"96,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-13","filed_date":"2025-03-13","scope":"insider"},{"id":8678508,"accession":"0001209191-23-016629","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016629","line_url":"/filing/0001209191-23-016629#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001915598","owner_name":"Friedl-Naderer Johanna","owner_display_name":"Friedl-Naderer Johanna","owner_url":"/insider/0001915598","role":"Officer (EVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1482.0,"shares_display":"1,482","price_per_share":22.82,"price_display":"22.82","price_state":"stated","total_value":33819.24,"total_display":"33,819.24","total_whole":"33,819","shares_owned_after":148518.0,"shares_owned_after_display":"148,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001818794","name":"Dyne Therapeutics, Inc.","url":"/issuer/0001818794","role":"Officer (Chief Commercial Officer)","n_filings":8,"first_seen":"2025-03-13","last_seen":"2026-08-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001706431","name":"Vir Biotechnology, Inc.","url":"/issuer/0001706431","role":"Officer (EVP & Chief Operating Officer)","n_filings":1,"first_seen":"2023-03-07","last_seen":"2023-03-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001915598","retrieved_at":"2026-08-25T19:45:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}